• Blog
  • Left Ventricular Assist Device Treatment Market Report

    Left Ventricular Assist Device Treatment Market Report

    Left Ventricular Assist Device Treatment Market Report
    Report code - SRHL225 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Left Ventricular Assist Device Treatment Market, Dynamics, Market Analysis
    See more...

    Market Insights

    The Global Left Ventricular Assist Device Treatment Market is expected to grow from USD 1.3 billion in 2020 to USD 2.4 billion by 2026 at a CAGR of over 11.1% during the forecast period.

    Figure: Global Left Ventricular Assist Device Treatment Market Size, 2020-2026 (USD Billion)

    Left-Ventricular-Assist-Device-Treatment-Market-Forecast

    Wish to get a free sample report? Click here.

    What is a ventricular assist device?

    A ventricular assist device also known as a mechanical circulatory support device is defined as an implantable mechanical pump that helps pump blood to the body from the lower chambers of the heart. A left ventricular assist device is used to treat patients who have reached end-stage heart failure. It helps the left ventricle to pump blood to the rest of the body.

    Key Players

    Key players operating in the global Left Ventricular Assist Device Treatment Market are-

    • Abbott Laboratories (The U.S),
    • Thoratec Corporation (The U.S.),
    • CorWave (France),
    • Apaxis Medical, Inc. (Canada)
    • Abiomed (The U.S),
    • HeartWare International Inc. (The U.S),
    • Berlin Heart GmbH (Germany),
    • Evaheart Inc (Japan),
    • Jarvik Heart, Inc. (The U.S), and
    • ReliantHeart, Inc. (The U.S).

    Market Dynamics

    The preference for ventricular assist devices is increasing over heart transplants due to the long waiting time for a donor’s heart which results in the death of the patient.

    • The growth of the global left ventricular assist device treatment market is primarily driven by the increasing prevalence of cardiovascular diseases particularly stroke and heart failure due to changing lifestyles and unhealthy eating habits.
    • The growing emphasis on technological advancements to develop miniature devices equipped with advanced features is likely to create lucrative growth opportunities for the players operating in the global left ventricular assist device treatment market during the review period.

    Segment Analysis

    Product Type Trends

    Based on product type, the market has been segmented into destination therapy, bridge to transplantation, bridge to recovery, and bridge to destination.

    • The destination therapy segment accounted for the largest market share in 2020 owing to the rise in the number of the patient having heart-related disease and end-stage heart failure.
    • The bridge to the transplantation segment is expected to grow at a substantial CAGR during the review period.

    Regional Trends

    Geographically, the market in North America accounted for the largest market share in 2020 and is projected to continue its dominance during the review period. The market growth can be attributed to the high demand for miniature devices equipped with advanced technology and the increasing prevalence of cardiovascular diseases.

    COVID-19 Impact on Global Left Ventricular Assist Device Treatment Market

    The Covis-19 outbreak did not affect the growth of the left ventricular assist device treatment market as unlike other medical problems the treatment of heart-related problems cannot be postponed. The American College of Cardiology (ACC) and Society of Cardiac Angiography and Interventions (SCAI) also established guidelines regarding considerations for patients referred for structural heart disease intervention during the Covid-19 pandemic.

    Critical Questions Answered in the Report

    • What are the key trends in the global left ventricular assist device treatment market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global left ventricular assist device treatment market?
    • What are the key strategies adopted by the major vendors to lead in the global left ventricular assist device treatment market?
    • What is the market share of the top vendors?

    Wish to get a full scope of the report? Click here

    Target Audience

    The following is a list of the customers that the Global left ventricular Assit Device treatment market aims to convert the most:

    • Left ventricular assist device treatment manufacturers.
    • Left ventricular assist device treatment suppliers.
    • Left ventricular assist device treatment distributors.
    • Organizations.
    • Government bodies.

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The left ventricular assist device treatment market is expected to witness an impressive growth of 11.1% CAGR in the foreseeable future.

    Abbott Laboratories (The U.S), Thoratec Corporation (The U.S.), CorWave (France), Apaxis Medical, Inc. (Canada), Abiomed (The U.S), HeartWare International Inc. (The U.S), Berlin Heart GmbH (Germany), Evaheart Inc (Japan), Jarvik Heart, Inc. (The U.S) and ReliantHeart, Inc. (The U.S) are among the key players in the left ventricular assist device treatment market.

    The left ventricular assist device treatment market size is expected to reach USD 2.4 billion in the coming years.

    North America is expected to remain dominant in the left ventricular assist device treatment market during the forecast period.

    The destination therapy segment accounted for the largest share of the left ventricular assist device treatment market in 2020.

    Increasing prevalence of cardiovascular diseases particularly stroke and heart failure due to changing lifestyles and unhealthy eating habits, The growing emphasis on technological advancements to develop miniature devices equipped with advanced features are the factors driving the growth of left ventricular assist device treatment market.

    Left ventricular assist device treatment manufacturers, Left ventricular assist device treatment suppliers, Left ventricular assist device treatment distributors, Organizations, Government bodies are the target audience in the left ventricular assist device treatment market.

    •